Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.
Explaining Chagas disease through the stories of patients in Latin America.
Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).
Explaining Chagas disease through the stories of patients in Bolivia.
A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.
Dr. Theophile Tuyisabe is one of only 18 ophthalmologists in Rwanda. We spoke with him about how he does it.
Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.
Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
This site is intended for a global audience.